Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines of care for the management of psoriasis and psoriatic arthritis
Alice B. Gottlieb, Neil J. Korman, Kenneth B. Gordon, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 5, pp. 851-864
Open Access | Times Cited: 768

Showing 1-25 of 768 citing articles:

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
C.E.M. Griffiths, Kristian Reich, Mark Lebwohl, et al.
The Lancet (2015) Vol. 386, Iss. 9993, pp. 541-551
Closed Access | Times Cited: 773
Psoriasis
Jacqueline Greb, Ari M. Goldminz, James T. Elder, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 741
Hidradenitis suppurativa: A comprehensive review
Ali Alikhan, Peter Lynch, Daniel B. Eisen
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 4, pp. 539-561
Closed Access | Times Cited: 660
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Kim Papp, Kristian Reich, Craig L. Leonardi, et al.
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 1, pp. 37-49
Open Access | Times Cited: 598
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 3, pp. 451-485
Closed Access | Times Cited: 532
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 4, pp. 643-659
Closed Access | Times Cited: 455
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
Laure Gossec, Josef S Smolen, C. Gaujoux-Viala, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 1, pp. 4-12
Open Access | Times Cited: 452
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 1, pp. 137-174
Closed Access | Times Cited: 444
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Arthur Kavanaugh, Philip J. Mease, Juan J. Gómez‐Reino, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1020-1026
Open Access | Times Cited: 425
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
Ehrin J. Armstrong, Caitlin T. Harskamp, April W. Armstrong
Journal of the American Heart Association (2013) Vol. 2, Iss. 2
Open Access | Times Cited: 407
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Peter Schäfer
Biochemical Pharmacology (2012) Vol. 83, Iss. 12, pp. 1583-1590
Closed Access | Times Cited: 395
Psoriasis: classical and emerging comorbidities
Maria de Fátima Santos Paim de Oliveira, Bruno de Oliveira Rocha, Gleison Vieira Duarte
Anais Brasileiros de Dermatologia (2015) Vol. 90, Iss. 1, pp. 9-20
Open Access | Times Cited: 350
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2009) Vol. 62, Iss. 1, pp. 114-135
Open Access | Times Cited: 341
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Gabrielle Kingsley, Anna Kowalczyk, Helen Taylor, et al.
Lara D. Veeken (2012) Vol. 51, Iss. 8, pp. 1368-1377
Open Access | Times Cited: 316
Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
A. Villani, Marie Rouzaud, M. Sevrain, et al.
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 2, pp. 242-248
Closed Access | Times Cited: 276
Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
Angelique N. Collamer, Daniel F. Battafarano
Seminars in Arthritis and Rheumatism (2010) Vol. 40, Iss. 3, pp. 233-240
Closed Access | Times Cited: 273
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 248
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Claudia Schinocca, Chiara Rizzo, Serena Fasano, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 245
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Helen Benham, P.G. NORRIS, Jane Goodall, et al.
Arthritis Research & Therapy (2013) Vol. 15, Iss. 5
Open Access | Times Cited: 232
The 5-point Investigator’s Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials
Richard Langley, Steven R. Feldman, Judit Nyirady, et al.
Journal of Dermatological Treatment (2013) Vol. 26, Iss. 1, pp. 23-31
Closed Access | Times Cited: 215
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
Hideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 11, pp. 1235-1270
Open Access | Times Cited: 213
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
Ian Landells, Colleen Marano, Ming-Chun Hsu, et al.
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 4, pp. 594-603
Open Access | Times Cited: 209
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
Mark Lebwohl, Arthur Kavanaugh, April W. Armstrong, et al.
American Journal of Clinical Dermatology (2015) Vol. 17, Iss. 1, pp. 87-97
Open Access | Times Cited: 197
Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
Caitriona Ryan, Muriel Sadlier, Edward De Vol, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 6, pp. 978-983
Closed Access | Times Cited: 186
Treatments for psoriasis and the risk of malignancy
Rita V. Patel, Lily Clark, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 6, pp. 1001-1017
Closed Access | Times Cited: 226
Page 1 - Next Page

Scroll to top